Healthcare Redesign of Medication Management for Parkinson’s Inpatients

Parkinson’s disease is a progressive neurological disorder reliant on medication regime adherence to alleviate symptomology. When hospitalised, people with Parkinson’s disease have specific medication management needs which are consistently unmet. This study aims to develop, implement and evaluate solutions for improving the medication management of inpatients with Parkinson’s disease. A healthcare redesign approach was utilised, focusing on the final three phases: solutions design, implementation and evaluation. Five solutions were derived: formalise routine patient identification, provide improved staff education, develop and install automated prescriber alerts, review and amend ward PD medication stock, and develop systematic prompts for PD medications. The findings suggest that our solutions sustainably improved systems and processes that contribute to quality and safe medication management for Parkinson’s patients. Correct identification of Parkinson’s patients within an acute care hospital leads to correct prescription of medications, timeliness of medication administration and timely pharmacy review. The length of stay was not positively impacted.

Authors

Institutions

Publication Details

Journal
Journal of Ageing and Longevity
Published
2025-09-15
DOI
https://doi.org/10.3390/jal5030033
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Healthcare Redesign of Medication Management for Parkinson’s Inpatients

Sarah Jane Prior, Susan Williams, M C Iannuzzi
Journal of Ageing and Longevity
Parkinson's Disease Mechanisms and Treatments
article

Healthcare Redesign of Medication Management for Parkinson’s Inpatients

Sarah Jane Prior, Susan Williams, M C Iannuzzi
article en

Abstract

Parkinson’s disease is a progressive neurological disorder reliant on medication regime adherence to alleviate symptomology. When hospitalised, people with Parkinson’s disease have specific medication management needs which are consistently unmet. This study aims to develop, implement and evaluate solutions for improving the medication management of inpatients with Parkinson’s disease. A healthcare redesign approach was utilised, focusing on the final three phases: solutions design, implementation and evaluation. Five solutions were derived: formalise routine patient identification, provide improved staff education, develop and install automated prescriber alerts, review and amend ward PD medication stock, and develop systematic prompts for PD medications. The findings suggest that our solutions sustainably improved systems and processes that contribute to quality and safe medication management for Parkinson’s patients. Correct identification of Parkinson’s patients within an acute care hospital leads to correct prescription of medications, timeliness of medication administration and timely pharmacy review. The length of stay was not positively impacted.

Journal of Ageing and LongevityVol. 5(3)
University of Tasmania (AU), Royal North Shore Hospital (AU)
Royal North Shore Hospital
Openalex Percentile: Top 64%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Healthcare Redesign of Medication Management for Parkinson’s Inpatients — Sarah Jane Prior, Susan Williams, et al. · Journal of Ageing and Longevity (2025) | TGRS Research Map | TGRS